Olmesartan Medoxomil/Amlodipine
Authors:
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 69 (6) , 717-729
Abstract
▴ Olmesartan medoxomil/amlodipine is a fixeddose combination of olmesartan medoxomil and amlodipine, both established antihypertensive agents. Dose titration with the individual constituent drugs is recommended before switching to the equivalent fixed-dose combination. ▴ In a randomized, double-blind, factorial trial in patients with mild to severe hypertension, 8 weeks of olmesartan medoxomil/amlodipine was more effective in reducing diastolic BP (DBP) and systolic BP (SBP) than placebo or equivalent dosages of olmesartan medoxomil or amlodipine as monotherapy. ▴ In two randomized, double-blind trials in patients with moderate to severe hypertension not adequately treated with amlodipine or olmesartan medoxomil monotherapy, 8 weeks of olmesartan medoxomil/amlodipine 20 mg/5 mg, 40 mg/5 mg or 40 mg/10 mg per day was more effective in reducing DBP and SBP than continuing treatment with olmesartan medoxomil 20 mg/day or amlodipine 5 mg/day monotherapy. ▴ More patients receiving olmesartan medoxomil/amlodipine at approved dosages than monotherapy recipients at equivalent dosages reached BP goals (42.5–51.0% vs 21.1–36.3% in the factorial trial and 44.5–54% vs 28.5–30% in the monotherapy comparisons). ▴ In the comparison with amlodipine monotherapy, >70% of olmesartan medoxomil/amlodipine recipients, some requiring upwards dosage adjustment, met BP goals. ▴ Olmesartan medoxomil/amlodipine was generally well tolerated in clinical trials. Peripheral oedema was significantly less common in olmesartan medoxomil/amlodipine 40 mg/10 mg per day than amlodipine monotherapy 10 mg/day recipients.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine MonotherapyClinical Drug Investigation, 2009
- Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose CombinationThe Journal of Clinical Pharmacology, 2008
- Evaluation of Population Pharmacokinetics and Exposure‐Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan MedoxomilThe Journal of Clinical Pharmacology, 2008
- The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety studyClinical Therapeutics, 2008
- Olmesartan MedoxomilDrugs, 2008
- Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor BlockerThe Journal of Clinical Hypertension, 2008
- Dihydropyridine Calcium Channel Antagonists in the Management of HypertensionDrugs, 2007
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United StatesJAMA, 2003
- AmlodipineDrugs, 1995